Leukemia Cutis
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement (NCT03701295) | National Cancer Institute (NCI) | 2020-03-06 |
| Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT01371981) | National Cancer Institute (NCI) | 2011-07-06 |
Track Leukemia Cutis automatically
Every clearance here is in the API, with alerts when new ones post.